Genus annual capital expenditures (capex)
2022
2023
2024
2025
2026
Genus Capital Expenditures (CapEx) Growth & History (GNS)
Genus's capital expenditures (capex) was £12.5M for fiscal 2026.
View full Genus company overviewGenus annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-06-30 | £12.5M | −£900,000 | −6.72% |
| 2025 | 2025-06-30 | £13.4M | −£1.4M | −9.46% |
| 2024 | 2024-06-30 | £14.8M | −£11.1M | −42.86% |
| 2023 | 2023-06-30 | £25.9M | −£16.2M | −38.48% |
| 2022 | 2022-06-30 | £42.1M | — | — |
Genus capital expenditures (capex) trends
Between the periods ended 2022-06-30 and 2026-06-30, Genus's capital expenditures (capex) decreased from £42.1M to £12.5M, a change of −£29.6M.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company official filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Genus source filings ↗Community posts
Genus announces a £60 million buyback after stronger annual earnings
Genus ($GNS-LSE) announced a £60 million share-buyback program after adjusted pre-tax profit rose 35% to £100.2 million. Revenue declined 2% to £658.1 million, but stronger profitability in its pig-genetics business and improvements in its ...
